As for any modality of clinical medicine, stem cell treatment requires an understanding of the underlying pathophysiology of the disease. It is imperative that clinicians who adopt these new strategies into their practices posssess a good understanding of the natural course of the targeted disease. It is also important for treating clinicians to have an enhanced understanding of different cell sources, with analysis of the reported population of native stem and progenitor cells.